Luminex Corporation
Biological testing technologies with applications throughout the life science and diagnostic industries
Luminex® was incorporated in May 1995 and is a publicly-traded company on the NASDAQ Stock Market under the symbol LMNX.
Patrick J. Balthrop (President, CEO)
Douglas C. Bryant (Executive VP, COO)
John C. Carrano (VP, R&D)
Harriss T. Currie (VP, Finance; CFO)
G. Walter Loewenbaum (Chairman)
Patrick J. Balthrop
Robert J. Cresci
Thomas W. Erickson
Fred C. Goad, Jr.
Jay B. Johnston
Jim D. Kever
Kevin M. McNamara
J. Stark Thompson
Gerard Vaillant
12212 Technology Blvd
Austin, TX 78727
USA
Phone: +1-512-219-8020
Fax: +1-512-219-5195
The xMAP® platform is the leading bead-based system for parallel protein analysis. The technology involves colour-coded beads and flow cytometry instrumentation. Up to 100 biological assays can be analysed simultaneously.
Related patents
Related news
- Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
- Luminex Corporation to Present at JP Morgan Healthcare Conference
- Luminex Corporation Reports Third Quarter 2011 Results
- Luminex Corporation Receives Deloitte Technology Fast 500(TM) Award
- Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
- Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
- Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
- Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
- Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
- Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis New CE Marked xTAG® Gastrointestinal Pathogen Panel (GPP) Used to Triage Patients at German Kliniken der Stadt Köln
- Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
- New CE Marked Test Simultaneously Detects Up To 95% of Gastrointestinal Infections in Under Five Hours
- Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011
- Luminex Corporation Wins Prestigious Medical Design Excellence Award
- Luminex Corporation to Present at Cowen and Company's 31st Annual Health Care Conference
- Luminex Corporation Ranked One of the 25 Fastest-Growing Technology Companies in America by Forbes for Third Consecutive Year
- Luminex Corporation Reports Fourth Quarter and Full Year 2010 Results
- Luminex Corporation Fourth Quarter and Full Year 2010 Earnings Release Scheduled for February 7, 2011
- Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
- Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
- Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
- Luminex Announces Commercial Launch of New Cystic Fibrosis Test
- Luminex Announces Commercial Launch of New Cystic Fibrosis Test
- Luminex Donates Company's First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
- Luminex Corporation Second Quarter 2010 Earnings Release Scheduled for August 5, 2010
- Luminex Corporation and High Throughput Genomics Launch the qBead Assay
- Luminex Corporation First Quarter Earnings Release Scheduled for May 6, 2010
- Luminex Announces New Strategic Initiatives at Annual Investor Day
- Northrop Grumman and Luminex Collaborate to Create Next Generation Autonomous Biodetectors
- Luminex Corporation to Webcast Annual Investor Presentation
- Luminex Corporation Reports Fourth Quarter and Full Year 2009 Results
- Luminex Corporation Fourth Quarter and Full Year 2009 Earnings Release Scheduled for February 4, 2010
- Luminex Corporation to Present at JP Morgan Healthcare Conference
- Luminex Corporation Reports Third Quarter 2009 Results
- Luminex Corporation Third Quarter Earnings Release Scheduled for November 4, 2009
- Luminex Corporation Launches New xTAGRVP.com Respiratory Virus Testing and Information Website
- Luminex Corporation Hosts Seventh Annual Planet xMAP Europe
- Luminex Corporation to Present at UBS Global Life Sciences Conference
- Luminex Receives 510(K) Clearance for New Cystic Fibrosis Test
- Luminex Corporation Reports Second Quarter 2009 Results
- Luminex Receives FDA Clearance for an Update to the xTAG(R) Respiratory Viral Panel Package Insert
- Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2009
- Luminex Corporation Names Tim Dehne Vice President of Systems and Research and Development
- Luminex Corporation Announces Executive Appointments
- Luminex Corporation Announces Full Commercial Launch of the High-Throughput FLEXMAP 3D(TM) Multiplexing System
- Luminex Launches Two New Cystic Fibrosis Tests in Europe
- Luminex Expands Globally and Opens Facility in People's Republic of China
- Luminex Holds Annual Meeting of Stockholders
- Luminex Corporation Reports First Quarter 2009 Results
- Luminex Corporation to Present at Bank of America and Merrill Lynch 2009 Health Care Conference
- Luminex Corporation Settles Legal Dispute
- Luminex Corporation Provides Interim Information on Sequence Analysis of Swine Flu and xTAG(R) RVP
- Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2009
- Luminex Announces Agenda for the Three-Day Planet xMAP USA Multiplexing Technology Symposium
- Luminex Corporation to Present at Cowen and Company Annual Healthcare Conference
- Luminex Unveils Keynote Speakers for Planet xMAP USA 2009
- Luminex Corporation Announces the Release of xPONENT(R) 3.1 Software
- Luminex Corporation to Webcast Investor Presentation
- Forbes Names Luminex Corporation One of the 25 Fastest-Growing Technology Companies in America
- Luminex Corporation Fourth Quarter and Year End 2008 Earnings
- Luminex Corporation Announces Organizational Change
- Luminex Corporation to Present at JPMorgan Healthcare Conference
- Luminex Corporation and Mingyuan Medicare Development Company Sign Distribution Agreement
- Luminex Corporation Announces First Commercial Shipment of FLEXMAP 3D Systems
- Luminex Corporation Third Quarter Earnings Release Scheduled for November 6, 2008
- Luminex Corporation Receives Clearance from Health Canada for xTAG(TM) Respiratory Viral Panel
- Luminex Corporation Hosts Sixth Annual Planet xMap Europe 2008 Symposium
- Luminex and BD Sign Agreement to Create Diagnostic Tests for Cancer
- Luminex Corporation to Present at UBS Global Life Sciences Conference
- Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
- Luminex Corporation to Present at Canaccord Adams Global Growth Conference
- Luminex Corporation Reports Second Quarter 2008 Results
- Luminex Corporation Second Quarter Earnings Release Scheduled for August 7, 2008
- Luminex Corporation and ViroNovative Announce License Agreement for Human Metapneumovirus Rights
- Luminex Corporation Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option
- Luminex Corporation Announces Public Offering of Common Stock
- Luminex Corporation Reports First Quarter 2008 Results
- Luminex Corporation First Quarter Earnings Release Scheduled for May 8, 2008
- Luminex Announces Executive Management Changes
- Luminex and Abbott Sign Agreement for Global Distribution of the xTAG(TM) Respiratory Viral Panel
- Luminex Corporation Places 5,000th Instrument
- Luminex Corporation to Host the Planet xMAP USA 2008 Multiplexing Symposium in Boston
- Luminex Corporation Reports Fourth Quarter and Year-End 2007 Results
- Luminex Corporation to Webcast Investor Presentation
- Luminex Corporation Fourth Quarter and Year-End 2007 Earnings Release Scheduled for February 7, 2008
- Luminex and Tyson Foods Sign Collaboration Agreement
- CORRECTING and REPLACING Luminex Corporation to Present At JPMorgan Healthcare Conference
- Luminex Corporation Receives U.S. Food and Drug Administration Clearance for xTAG(TM) Respiratory Viral Panel
- Luminex Corporation Launches FlexmiR Select
- Luminex Announces Development Collaboration and License Agreement with Major Healthcare and Research Organization
- Luminex Corporation Announces Finalization of the Purchase Price Allocation Related to Tm Bioscience Acquisition
- Rules-Based Medicine Merges with EDI GmbH
- Luminex Corporation Reports Third Quarter 2007 Results
- Luminex Corporation Third Quarter Earnings Release Scheduled for October 24, 2007
- Luminex Corporation Reaches Settlement With Rules Based Medicine, Inc.
- Luminex Corporation Third Quarter Earnings Release Scheduled for October 24, 2007
- Luminex Corporation to Present at Biotechnology Industry Organization Investor Forum
- Luminex Corporation to Present at ThinkEquity Partners Investor Conference
- Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
- Luminex Corporation Completes a Portion of its Purchase Price Allocation
- Luminex Corporation to Present at Leerink Swann Conference
- Luminex Corporation to Present at Canaccord Adams Global Growth Conference
- Luminex Corporation Reports Second Quarter 2007 Results
- Luminex Corporation Second Quarter Earnings Release Scheduled for July 25, 2007
- Luminex Corporation Names Douglas C. Bryant as Executive Vice President and Chief Operating Officer
- Luminex Corporation Second Quarter Earnings Release Scheduled for July 25, 2007
- Luminex and Exiqon Sign Distribution Agreement for MicroRNA Products and Launch Expanded Product Line
- Luminex Corporation Reports First Quarter 2007 Results ------------------------- Core Business Achieves Record Revenue and Profit Integration of New Luminex Molecular Diagnostics Division Moving Forward
- Luminex Licenses Cystic Fibrosis Gene Patent From John Hopkins University
- Luminex Corporation First Quarter Earnings Release Scheduled for May 2, 2007
- Luminex Corporation Launches xPONENT(TM) Software and MagPlex(TM) Magnetic Microspheres
- Luminex Corporation Launches xPONENT(TM) Software and MagPlex(TM) Magnetic Microspheres
- Luminex Corporation And Tm Bioscience Corporation Announce Completion Of Acquisition Of Tm Bioscience By Luminex
- Luminex Corporation to Webcast Investor Presentation
- Luminex Corporation Hosts Planet xMAP USA Technology Symposium
- Luminex Corporation Reports Fourth Quarter and Year-End 2006 Results
- Luminex Corporation Fourth Quarter and Year-End 2006 Earnings Release Scheduled for February 7, 2007
- Luminex Corporation Fourth Quarter and Year-End 2006 Earnings Release Scheduled for February 7, 2007
- Luminex Corporation to Present at JP Morgan Healthcare Conference
- Luminex Signs Agreement With Fisher HealthCare
- Luminex and Exiqon Introduce MicroRNA Product Line
- Luminex Corporation Announces Agreement to Acquire Tm Bioscience
- Luminex Corporation Reports Third Quarter 2006 Results
- Luminex Corporation Announces Market Release of Pneumococcal Assay
- Luminex Corporation Third Quarter Earnings Release Scheduled for October 25, 2006
- Luminex Corporation Launches New Certified Developer Program
- Luminex Corporation Hosts Planet xMAP Europe Technology Symposium October 3-4, 2006
- Luminex and Exiqon Announce Development and Commercialization Agreement
- Luminex Corporation and Smiths Detection Receive Contract From Department of Homeland Security
- Luminex Corporation Reports Second Quarter 2006 Results
- Luminex Corporation Receives Research Grant from the Department of the Army
- Luminex Corporation Second Quarter Earnings Release Scheduled for July 26, 2006
- Luminex Corporation Second Quarter Earnings Release Scheduled for July 26, 2006
- Luminex Corporation to Present at Pacific Growth Equities Life Sciences Growth Conference
- Luminex Corporation Reports First Quarter 2006 Results
- Luminex Corporation Hosts Planet xMAP Technology Symposium
- Luminex Corporation First Quarter Earnings Release Scheduled for April 26, 2006
- Luminex Corporation First Quarter Earnings Release Scheduled for April 26, 2006
- Luminex Corporation to Present at 2006 Lehman Brothers Conference
- Luminex Corporation Announces Licensing Agreement for the Development and Commercialization of MicroRNA Products
- Luminex Corporation Announces Formation of New Scientific Advisory Board
- Luminex Corporation Reports Fourth Quarter and Year-end 2005 Results
- Luminex Corporation to Webcast Investor Presentation